| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/06/2012 | US20120309758 Modulators of atp-binding cassette transporters |
| 12/06/2012 | US20120309754 Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| 12/06/2012 | US20120309748 Conjugated psychotropic drugs and uses thereof |
| 12/06/2012 | US20120309747 Protein kinase inhibitors |
| 12/06/2012 | US20120309746 Triazolopyridine compounds |
| 12/06/2012 | US20120309743 Thiolactams and uses thereof |
| 12/06/2012 | US20120309742 Use of metabotropic glutamate receptors |
| 12/06/2012 | US20120309737 3,6-Diazabicyclo[3.1.1]heptanes as Neuronal Nicotinic Acetycholine Receptor Ligands |
| 12/06/2012 | US20120309721 Method for providing neuroprotection |
| 12/06/2012 | US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives |
| 12/06/2012 | US20120309716 Motor Function Improver |
| 12/06/2012 | US20120309714 Heteroaromatic Phenylimidazole derivatives as PDE10A enzyme inhibitors |
| 12/06/2012 | US20120309707 Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases |
| 12/06/2012 | US20120309700 Development and evaluation of novel chinese materia medica preparations |
| 12/06/2012 | US20120309699 Compounds having anti-inflammatory activity |
| 12/06/2012 | US20120309688 Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application |
| 12/06/2012 | US20120309687 Glioprotectant Peptide for Use in the Treatment of Amyotrophic Lateral Sclerosis (ALS) and Methods Related Thereto |
| 12/06/2012 | US20120309683 USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
| 12/06/2012 | US20120309679 Igf-i poly (ethylene glycol) conjugates |
| 12/06/2012 | US20120309673 Cysteine protease inhibitors |
| 12/06/2012 | US20120308674 Composition and method for the treatment of neuropathic pain |
| 12/06/2012 | US20120308673 Composition comprising the extract of prunella vulgaris l. for preventing and treating adhd disease and the use thereof |
| 12/06/2012 | US20120308668 Mazindol combination in the treatment of attention deficit/hyperactivity |
| 12/06/2012 | US20120308654 Abuse-proofed dosage form |
| 12/06/2012 | US20120308647 Use of mir-30e to treat vascular lesions |
| 12/06/2012 | US20120308644 Compositions for mucosal delivery of agents |
| 12/06/2012 | US20120308614 Composition for the controlled release of buprenorphine |
| 12/06/2012 | US20120308608 Interferon-inducing compounds and uses thereof |
| 12/06/2012 | US20120308606 Bicyclic derivatives as modulators of voltage gated ion channels |
| 12/06/2012 | US20120308595 Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease |
| 12/06/2012 | US20120308589 Sinomenine derivatives, synthetic methods and uses thereof |
| 12/06/2012 | US20120308588 Neprilysin inhibitors |
| 12/06/2012 | US20120308586 Composition based on extra virgin olive oils |
| 12/06/2012 | US20120308585 Methods and compositions for use in cellular therapies |
| 12/06/2012 | US20120308581 Compositions and methods for detecting tlr3 |
| 12/06/2012 | US20120308573 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 12/06/2012 | US20120308572 Protofibril-Binding Antibodies and Their Use in Therapeutic and Diagnostic Methods for Parkinson's Disease, Dementia with Lewy Bodies and Other Alpha-Synucleinopathies |
| 12/06/2012 | US20120308554 Vegf-d/vegfr2/3-mediated regulation of dendrites |
| 12/06/2012 | US20120308550 Method of Using Fish Plasma Components to Promote Functional Recovery in the Mammialian CNS |
| 12/06/2012 | US20120308547 Compositions and methods of using chondroitinase abci mutants |
| 12/06/2012 | US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment |
| 12/06/2012 | US20120308534 Neural progenitor cell populations |
| 12/06/2012 | US20120308530 Materials Composition and Methods to Control Neural Progenitor and Stem Cell Attachment, Proliferation and Guide Cell Differentiation |
| 12/06/2012 | US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 12/06/2012 | US20120308514 Human antibodies that bind human il-12 and methods for producing |
| 12/06/2012 | US20120308493 Pawpaw and/or peach derived composition |
| 12/06/2012 | US20120308483 Treatment of Sleep Disturbances |
| 12/06/2012 | US20120308480 Humanized antibodies against tl1a |
| 12/06/2012 | CA2843126A1 Clenbuterol for use in treatment of autism |
| 12/06/2012 | CA2837898A1 Method of treating the effects of stroke |
| 12/06/2012 | CA2837657A1 Compositions for sequential administration of opioid receptor agonists |
| 12/06/2012 | CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies |
| 12/06/2012 | CA2837382A1 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders |
| 12/06/2012 | CA2837046A1 Novel use of rice, rice bran or rice hull extract as a histamine receptor antagonist |
| 12/06/2012 | CA2834832A1 Vegf-d/vegfr2/3-mediated regulation of dendrites |
| 12/06/2012 | CA2834742A1 A method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders |
| 12/06/2012 | CA2833813A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors |
| 12/05/2012 | EP2530078A1 Thiazole derivative |
| 12/05/2012 | EP2530075A2 Modulators of ATP-binding cassette transporters |
| 12/05/2012 | EP2530072A1 New compounds, synthesis and use thereof in the treatment of pain |
| 12/05/2012 | EP2529745A1 VEGF-D/VEGFR mediated regulation of dendrites |
| 12/05/2012 | EP2529005A1 Use of hydrogels on the basis of guluronic acid- and/or mannuronic acid-containing polysaccharides for treating damage to the nervous system, promoting nerve growth, treating neurodegenerative diseases and cultivating neurons |
| 12/05/2012 | EP2528917A1 Pyrazolopyridine kinase inhibitors |
| 12/05/2012 | EP2528916A1 Pyrazolopyridine kinase inhibitors |
| 12/05/2012 | EP2528911A2 Compositions and methods for enhancing proteasome activity |
| 12/05/2012 | EP2528902A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 12/05/2012 | EP2528898A2 NOVEL COMPOSITIONS FOR REDUCING Aß 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) |
| 12/05/2012 | EP2528617A1 Cytokines for the treatment of addictions |
| 12/05/2012 | EP2528598A1 Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent |
| 12/05/2012 | EP2528595A1 Compounds for use in the treatment of diseases |
| 12/05/2012 | EP2528441A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 12/05/2012 | CN102812037A Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same |
| 12/05/2012 | CN102812028A Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 12/05/2012 | CN102812017A Pyrazine derivatives |
| 12/05/2012 | CN102812014A Novel Oxime Derivatives And Their Use As Allosteric Modulators Of Metabotropic Glutamate Receptors |
| 12/05/2012 | CN102812005A Inhibitors of beta-secretase |
| 12/05/2012 | CN102811728A Boswellia oil, its fractions and compositions for enhancing brain function |
| 12/05/2012 | CN102811722A Treatment of loss of sense of touch with saxitoxin derivatives |
| 12/05/2012 | CN102811716A Compounds for the treatment of autism |
| 12/05/2012 | CN102807617A Antibodies to M-CSF |
| 12/05/2012 | CN102807613A Secreted protein with chemotactic activity and medicament usage thereof |
| 12/05/2012 | CN102807575A 3-aryl-5-thienyl-5H-thiazolo [3,2-a] pyrimidine derivative and application thereof |
| 12/05/2012 | CN102807569A Compound with clam and hypnosis functions, and preparation method and application thereof |
| 12/05/2012 | CN102807568A Thiadiazole derivative DPP-IV (dipeptidyl peptidase IV) inhibitor |
| 12/05/2012 | CN102807558A Fluorine-containing dihydroindene amide compound used as protein kinase inhibitor |
| 12/05/2012 | CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 12/05/2012 | CN102807526A Preparation method and application of histone deacetylase inhibitor ZYJ-D08a and epimer thereof |
| 12/05/2012 | CN102805849A Method for preparing traditional Chinese medicine for treating heart and gallbladder deficiency type insomnia |
| 12/05/2012 | CN102805841A Medicament for treating adverse reaction caused by anesthetics |
| 12/05/2012 | CN102805839A Method for preparing traditional Chinese medicine for treating insomnia caused by precordial pain |
| 12/05/2012 | CN102805838A Preparation method of traditional Chinese medicine for treating insomnia due to intense liver fire |
| 12/05/2012 | CN102805833A Medicinal extract composition for treating psychoneurosis and preparation method and preparation thereof |
| 12/05/2012 | CN102805813A Method for preparing traditional Chinese medicine for treating chilli addiction type insomnia |
| 12/05/2012 | CN102805812A Preparation method of traditional Chinese medicine for treating insomnia due to garlic adephagia |
| 12/05/2012 | CN102805801A Preparation method of traditional Chinese medicine for treating smoking type insomnia |
| 12/05/2012 | CN102805800A Traditional Chinese medicine composition for treating neurodermatitis |
| 12/05/2012 | CN102805790A External plaster for treating rheumatism and cancer pain |
| 12/05/2012 | CN102805784A Preparation Method of traditional Chinese medicine for treating pruritus type insomnia |
| 12/05/2012 | CN102805779A Traditional Chinese medicine composition for treating insomnia |
| 12/05/2012 | CN102805758A New application of fragrant sarcococca herb total alkaloid |